GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Champions Oncology Inc (NAS:CSBR) » Definitions » Tax Rate %

CSBR (Champions Oncology) Tax Rate % : 1.49% (As of Oct. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Champions Oncology Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Champions Oncology's Tax Expense for the three months ended in Oct. 2024 was $0.01 Mil. Champions Oncology's Pre-Tax Income for the three months ended in Oct. 2024 was $0.74 Mil. Therefore, Champions Oncology's Tax Rate % for the quarter that ended in Oct. 2024 was 1.49%.

Champions Oncology Tax Rate % Historical Data

The historical data trend for Champions Oncology's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Champions Oncology Tax Rate % Chart

Champions Oncology Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.62 17.16 6.00 -1.29 0.44

Champions Oncology Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.53 -0.44 42.93 1.57 1.49

Champions Oncology Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Champions Oncology's Tax Rate % for the fiscal year that ended in Apr. 2024 is calculated as

Tax Rate %=Tax Expense (A: Apr. 2024 )/Pre-Tax Income (A: Apr. 2024 )
=-0.032/-7.308
=0.44 %

Champions Oncology's Tax Rate % for the quarter that ended in Oct. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Oct. 2024 )/Pre-Tax Income (Q: Oct. 2024 )
=0.011/0.739
=1.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Champions Oncology Tax Rate % Related Terms

Thank you for viewing the detailed overview of Champions Oncology's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Champions Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Champions Oncology Inc (NAS:CSBR) » Definitions » Tax Rate %
Comparable Companies
CELU SPRO ALVR CUE ENTX CLRB IMRX XFOR ATRA MURA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
One University Plaza, Suite 307, Hackensack, NJ, USA, 07601
Website
https://www.championsoncology.com
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Executives
Daniel Newman Mendelson director COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817
Ronnie Morris director, officer: President 855 N. WOLFE STREET, SUITE 619, BALTIMORE MD 21205
Philip P. Breitfeld director ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK NJ 07601
New Enterprise Associates 14, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Neeraj Agrawal 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Roger H Lee 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Michael Maurice Brown 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Battery Management Corp. 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
R David Tabors 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Jesse Feldman 10 percent owner ONE MARINA PARK DRIVE, SUITE 1100, BOSTON MA 02210
Joel Ackerman director, officer: Chief Executive Officer COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR SUITE 900, BETHESDA MD 20817
Patrick J Kerins 10 percent owner
Ryan D Drant 10 percent owner 1119 ST PAUL STREET, BALTIMORE MD 21202
Harry R Weller 10 percent owner 1119 ST. PAUL STREET, BALTIMORE MD 21202
Florence Anthony A. Jr. 10 percent owner 5425 WISCONSIN AVENUE, SUITE 800, CHEVY CHASE MD 20815